• The power of local knowledge
    on a global scale.

    No matter where your clinical development takes you, we're already there. Where are you today?

  • We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

  • There's just no denying
    good chemistry

    Explore the PRA HEALTH SCIENCES interactive experience to find out what makes us tick.

Social Media

See the latest interactions from our social media


Rodeina Challand (Executive Director, #Biosimilar Development) will be presenting "Challenges in Demonstrating...

View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences, Inc. Announces Pricing of its Initial Public Offering

12 November 2014, Raleigh, N.C. – PRA Health Sciences, Inc. (“PRA”), a leading global contract research organization, today announced the pricing of its initial public offering of...

PRA Health Sciences Files for Initial Public Offering

08 September 2014, Raleigh, N.C. PRA Health Sciences, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC)...

PRA Health Sciences Expands in Pennsylvania

26 August 2014, Blue Bell, PA – Blue Bell, Pennsylvania will soon be home to PRA Health Sciences’ largest office worldwide. PRA, a leading global Contract Research Organization (CRO), is...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

FACT SHEET: Oncology & Hematology
November 17, 2014

During the last 5 years, PRA has participated in more than 400 oncology and hematology clinical projects globally

FACT SHEET: Infectious Diseases
November 17, 2014

Our infectious diseases experts pioneered the innovative evidence-based methodology used at PRA to ensure successful start-up and conduct of our clients’ global studies

Whitpaper - Global Biosimilar Development
October 28, 2014

Many different terms are used in different parts of the world to describe “biosimilar products.” It is important to understand and differentiate true biosimilars from others because of the potential concern for patient safety and efficacy.


Find out what's happening next on PRA's event schedule

November 19 - November 21

In the program outline we identified 5 major themes where we want to travel with you beyond the horizon. For each theme we provide a few program topics. In the spirit of a true Forum, we will build an agenda reflecting your interest, contributions and engagement. Depending on your submissions, some program topics will become […]

November 20 - November 22

The development of the next generation of Alzheimer’s disease treatments is among the most important health needs worldwide, but presents huge challenges. The goal of the meeting is to bring together today’s worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues important to the development of the […]

November 20 - November 23

The Scottsdale Headache Symposium® continues to be a successful venue for providing practical, clinical, evidence-based information on the diagnosis, management, and treatment of headache patients. Education is presented in didactic, case-based, evidence-based, panel, and demonstrative formats. AHS celebrates over 56 years of leading and serving the headache community.

Read More >